表紙
市場調查報告書
商品編碼
827290

腎臟及泌尿器官系統疾病療法設備類的全球市場:2019年∼2023年

Global Nephrology and Urology Devices Market 2019-2023

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 140 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

創新技術的出現是未來幾年促進腎髒病學和泌尿學設備市場增長的關鍵因素之一。供應商正在加大研發技術先進設備的研發力度。此外,這些進步還將有助於開發具有連接功能的用戶友好,輕量級和家用高清機器,以便在實時場景中遠程監控患者。因此腎臟及泌尿器官系統疾病療法設備類的全球市場從2019年到2023年這段期間將以超越5%的年複合成長率 (CAGR) 持續擴大。

本報告涵括腎臟及泌尿器官系統疾病療法設備類的全球市場,透過對市場成長促進因素和市場課題,市場趨勢,以及市場競爭情形的詳細調查,來進行市場現狀分析以及未來預測。

第1章 摘要整理

第2章 本報告涵蓋範圍

  • 序言
  • 對美金的匯率

第3章 市場概況

  • 市場生態系統
  • 市場特徵
  • 市場分類分析

第4章 市場規模

  • 市場定義
  • 市場規模估計
  • 現行市場規模及未來市場規模預測

第5章 波特的五力分析

  • 買方議價能力
  • 賣主談判力
  • 新加入企業帶來的威脅
  • 替代品帶來的威脅
  • 企業間的競爭關係
  • 市場情形

第6章 各產品市場分類

  • 各產品市場分類
  • 各產品比較
  • 腎透析設備 - 市場規模及未來預測
  • 尿失禁用設備 - 市場規模及未來預測
  • 腎臟結石/尿結石療法設備 - 市場規模及未來預測
  • 前列腺肥大症療法設備 - 市場規模及未來預測
  • 其他的設備 - 市場規模及未來預測
  • 各產品市場機會

第7章 客戶情形

第8章 地區市場情形

  • 地區市場分類
  • 地區市場比較
  • 北美 - 市場規模及未來預測
  • 歐洲 - 市場規模及未來預測
  • 亞洲 - 市場規模及未來預測
  • 其他地區 - 市場規模及未來預測
  • 主要國家
  • 市場機會

第9章 決策要素架構

第10章 市場成長推動因素與課題

  • 市場成長促進因素
  • 市場課題

第11章 市場趨勢

  • 家庭透析治療需求上升
  • 尿失禁的薦椎神經刺激療法需求增加
  • 輸尿管鏡下碎石術需求的增加

第12章 業者情勢

  • 概要
  • 形勢的快速發展

第13章 主要供應商分析

  • 調查交易廠商
  • 供應商類別
  • 各供應商的市場定位
  • B. Braun Melsungen AG
  • Baxter
  • BD
  • Boston Scientific Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Olympus Corporation

第14章 附錄

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR31146

About this market

The emergence of innovative technologies is one of the key factors expected to foster the nephrology and urology devices market growth in the forthcoming years. Vendors are increasing their R&D efforts in introducing technologically advanced devices. In addition, these advances will also help in developing user-friendly, light-weight, and at-home HD machines with connectivity features for monitoring the patients remotely in real-time scenarios. This will eventually contribute to the market growth during the forecast period. Technavio's analysts have predicted that the nephrology and urology devices market will register a CAGR of more than 5% by 2023.

Market Overview

Increasing prevalence nephrology and urology diseases

One of the growth drivers of the global nephrology and urology devices market is the increasing prevalence nephrology and urology diseases. The number of cases with urology diseases will increase, especially in developing countries such as China and India where the number of older significantly increasing.

The high cost of devices and treatment

One of the challenges in the growth of the global nephrology and urology devices market is the high cost of devices and treatment. End users must also bear the additional costs on the maintenance of these devices, post-operative device adjustments, and on replacing their battery.

For the detailed list of factors that will drive and challenge the growth of the nephrology and urology devices market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately concentrated with the presence of a few market players. Vendors in the market are increasing their R&D efforts to cater to patients opting for home dialysis. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Renal dialysis devices - Market size and forecast 2018-2023
  • UI devices - Market size and forecast 2018-2023
  • Urolithiasis devices - Market size and forecast 2018-2023
  • BPH devices - Market size and forecast 2018-2023
  • Other devices - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Rising demand for home dialysis treatment
  • Increasing demand for sacral neuromodulation for UI
  • Increasing demand for ureteroscopic lithotripsy

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • B. Braun Melsungen AG
  • Baxter
  • BD
  • Boston Scientific Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Olympus Corporation

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global medical devices market
  • Exhibit 02: Segments of global medical devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Product - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Renal dialysis devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Renal dialysis devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: UI devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: UI devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Urolithiasis devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Urolithiasis devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: BPH devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 26: BPH devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 27: Other devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: Other devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Market opportunity by product
  • Exhibit 30: Customer landscape
  • Exhibit 31: Market share by geography 2018-2023 (%)
  • Exhibit 32: Geographic comparison
  • Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 41: Key leading countries
  • Exhibit 42: Market opportunity
  • Exhibit 43: Unadjusted incidence rate of individuals who had commenced RRT for ESRD in 2015 (per 100,000 population) in various countries
  • Exhibit 44: Impact of drivers and challenges
  • Exhibit 45: Vendor landscape
  • Exhibit 46: Landscape disruption
  • Exhibit 47: Vendors covered
  • Exhibit 48: Vendor classification
  • Exhibit 49: Market positioning of vendors
  • Exhibit 50: B. Braun Melsungen AG - Vendor overview
  • Exhibit 51: B. Braun Melsungen AG - Business segments
  • Exhibit 52: B. Braun Melsungen AG - Organizational developments
  • Exhibit 53: B. Braun Melsungen AG - Geographic focus
  • Exhibit 54: B. Braun Melsungen AG - Segment focus
  • Exhibit 55: B. Braun Melsungen AG - Key offerings
  • Exhibit 56: B. Braun Melsungen AG - Key customers
  • Exhibit 57: Baxter - Vendor overview
  • Exhibit 58: Baxter - Business segments
  • Exhibit 59: Baxter - Organizational developments
  • Exhibit 60: Baxter - Geographic focus
  • Exhibit 61: Baxter - Segment focus
  • Exhibit 62: Baxter - Key offerings
  • Exhibit 63: Baxter - Key customers
  • Exhibit 64: BD - Vendor overview
  • Exhibit 65: BD - Business segments
  • Exhibit 66: BD - Organizational developments
  • Exhibit 67: BD - Geographic focus
  • Exhibit 68: BD - Segment focus
  • Exhibit 69: BD - Key offerings
  • Exhibit 70: BD - Key customers
  • Exhibit 71: Boston Scientific Corporation - Vendor overview
  • Exhibit 72: Boston Scientific Corporation - Business segments
  • Exhibit 73: Boston Scientific Corporation - Organizational developments
  • Exhibit 74: Boston Scientific Corporation - Geographic focus
  • Exhibit 75: Boston Scientific Corporation - Segment focus
  • Exhibit 76: Boston Scientific Corporation - Key offerings
  • Exhibit 77: Boston Scientific Corporation - Key customers
  • Exhibit 78: Fresenius Medical Care AG & Co. KGaA - Vendor overview
  • Exhibit 79: Fresenius Medical Care AG & Co. KGaA - Product segments
  • Exhibit 80: Fresenius Medical Care AG & Co. KGaA - Organizational developments
  • Exhibit 81: Fresenius Medical Care AG & Co. KGaA - Geographic focus
  • Exhibit 82: Fresenius Medical Care AG & Co. KGaA - Segment focus
  • Exhibit 83: Fresenius Medical Care AG & Co. KGaA - Key offerings
  • Exhibit 84: Fresenius Medical Care AG & Co. KGaA - Key customers
  • Exhibit 85: Olympus Corporation - Vendor overview
  • Exhibit 86: Olympus Corporation - Business segments
  • Exhibit 87: Olympus Corporation - Organizational developments
  • Exhibit 88: Olympus Corporation - Geographic focus
  • Exhibit 89: Olympus Corporation - Segment focus
  • Exhibit 90: Olympus Corporation - Key offerings
  • Exhibit 91: Olympus Corporation - Key customers
  • Exhibit 92: Validation techniques employed for market sizing